Agenda

Moderator:

Presidential Address

Bethany M. Anderson, MD
University of Wisconsin

Panelists:

How Should Curriculums Be Developed?

Jennifer M. Croke, MD, MHPE
Princess Margaret Cancer Centre

Development of Physicist Brachytherapy Training Standards

Christopher Deufel, PhD
Mayo Clinic

Development of Physician Brachytherapy Training Standards

Mira Keyes, MD, FABS
BC Cancer

Resident’s Perspective on Creating Brachytherapy Training Standards

Bailey Nelson, MD
University of Cincinnati

What is the Role of Industry in Brachytherapy Education?

Neil Taunk, MD
University of Pennsylvania

Panelists:

Peter F. Orio, III, DO, MS, FABS
Brigham and Women’s Hospital

Moderator:

Daniel G. Peteriet MD, FABS
Monument Health

Panelists:

Lauren Andring, MD
MD Anderson

Jonathan Cantalino, DO, MS
MedStar Health Georgetown University Hospital

Andrew M. Farach, MD
Houston Methodist Hospital

Jay Shiao, MD
University of Kansas

Moderator:

Mitchell Kamrava, MD, MHDS

Moderator:

Martin King, MD
Brigham and Women’s Hospital

Panelists:

Monotherapy: Pushing the Limits

Jay Ciezki, MD,
Cleveland Clinic

Bimodality: Can we Add EBRT and Avoid ADT?

Alfonso Gomez Iturriaga, MD
Cruces University Hospital

Trimodality: When Do We Add ADT and When Can We Avoid it?

Marisa Kollmeier, MD
Memorial Sloan Kettering

Moderators:

Parul N. Barry, MD
University of Pittsburgh

Lucas Mendez, MD
London Health Science Centre

 

Updated Trends In Brachytherapy Utilization In The United States From 2004 To 2020

 

Starting Interstitial, Image Guided Adaptive Brachytherapy In Botswana: Initial Experience In A High Volume, Low Resource Centre

 

Clinical Implementation Of MRI-only Treatment Planning (MRTP) Workflow For Gynecological HDR Brachytherapy

 

Definitive Radiation For Advanced Cervix Cancer Is Not Associated With Vaginal Shortening - A Prospective Vaginal Length And Dose Correlation

 

Gastrointestinal And Genitourinary Toxicity Following High Dose Rate Vaginal Cuff Brachytherapy With 21 Gray In 3 Fractions For Endometrial Cancer

 

Including Religion & Spirituality To Improve Patient-physician Communication For Gynecologic Brachytherapy Patients

Moderators:

Joelle Helou, MD, MSc
Princess Margaret Cancer Centre

Chad Tang, MD
MD Anderson Cancer Center

 

Health-related Quality Of Life After Combined External Beam And Either High Dose Rate (HDR) Or Low Dose Rate (LDR) Brachytherapy: Does The Rectal Dose From The LDR Brachytherapy Make A Difference?

 

Long Term Rectal Patient-reported Quality Of Life Outcomes Among Patients Treated With Pd-103 Ldr Prostate Brachytherapy

 

Prostate Brachytherapy With Cs-131: Long Term Results Compared To Published SBRT Data

 

The Performance Of Multiparametric MRI In Identification Of Intraprostatic Tumor Deposits After Local Prostate Radiation Therapy

 

Comparison Of Perioperative & Subacute Postoperative Complications Between LDR & HDR Brachytherapy For Prostate Cancer

Moderator:

Kevin Albuquerque, MD
UT Southwestern Medical Center

Panelists:

Simplifying Complex Perineal Template Brachytherapy

Eric Leung, MD
Sunnybrook Odette Cancer Centre

Efficient Use of Advanced Hybrid Cervical Applicators

Scott Glaser, MD
City of Hope

AI-Assisted Contouring/Needle Reconstruction

Alexandra Rink, PhD
Princess Margaret Cancer Centre

Preparing for Acute Complications

Kristin Bradley, MD
University of Wisconsin

Moderator:

Tiffany Phillips, PhD
Cedars-Sinai Medical Center

Panelists:

Appropriate Patient Selection for Skin Brachytherapy

Michael Kasper, MD
Christine E. Lynn Cancer Center at Boca Raton Regional Hospital

Choosing the Right Technique for Skin Brachytherapy

Parag Sanghvi, MD
University of California, San Diego

Dosimetry Considerations: Physics Perspective

Joel Poder, MSc
St George Hospital Cancer Care Centre

Practical Clinical Considerations: Therapist's Perspective

Mackenzie Smith, MRT(T)
Sunnybrook Odette Cancer Centre

Moderator:

Simona Shaitelman, MD, EdM
UT MD Anderson Cancer Center

Panelists:

APBI (and Brachytherapy Specifically) is the Preferred Option for Early-Stage Breast Cancer

Jaroslaw T. Hepel, MD
Rhode Island Hospital, Brown University

ABS APBI Guidelines Update 2023

Bethany M. Anderson, MD
University of Wisconsin

Eliminating Barriers to Breast Brachytherapy

Bridget Quinn, MD, PhD
VCU Health

Ultra-Short Course Breast Brachytherapy

Jean-Michel Hannoun-Levi, MD, PhD
Antoine Lacassagne Cancer Center

Moderators:

Andrew M. Farach, MD
Houston Methodist Hospital

Michael T. Folkert, MD, PhD
Northwell Health

Panelists:

Rectal Cancer

Te Vuong, MD, FRCP
Jewish General Hospital

Bladder Cancer

Andrew M. Farach, MD
Houston Methodist Hospital

Esophageal Cancer

Nitika Thawani, MD
Dignity Health Cancer Institute

Repeat Breast Conservation Therapy with Breast Brachytherapy

Jean-Michel Hannoun-Levi, MD, PhD
Antoine Lacassagne Cancer Center

Moderators:

Deidre Batchelar, PhD, FCCPM
BC Cancer Agency

Christopher Tien, PhD
Yale University School of Medicine

Panelists:

A Practical Quality Assurance Program

Deidre Batchelar, PhD, FCCPM
BC Cancer Agency

Hardware Commissioning

Susan Richardson, PhD
Swedish Cancer Institute

TPS and Software Commissioning

Samantha Simiele, PhD
MD Anderson Cancer Center

Moderators:

Subhakar Mutyala, MD, MPH
Arizona Oncology

Puja S. Venkat, MD
UCLA

Panelists:

Brachytherapy for Extrapelvic Malignancies

Albert Chang, MD, PhD
UCLA

3D Printed HDR Brachytherapy Applicators

John David, MD
Tampa General

Penile Cancer Applicators

Aurelie Garant, MD
UT Southwestern Medical Center

3D Printing for Eye Plaques

Firas Mourtada, PhD
Thomas Jefferson University

Moderators:

Sonja Dieterich, PhD, MBA
UC Davis

Daniel J. Scanderbeg, PhD
University of California San Diego

Panelists:

Remote Education

Benjamin Li, MD
Rayos Contra Cancer

Remote Chart Rounds, Contouring, and Planning

Anuja Jhingran, MD
MD Anderson Cancer Center

Moderators:

Mark J. Rivard, PhD, FABS
Rhode Island Hospital/Brown University

Yiwen Xu, PhD
British Columbia Cancer Agency

 

To Measure Or Not To Measure? Investigating The Dosimetric Impact Of Measured Vs Reconstructed Needle Depths During Intraoperative US-guided Prostate HDR

 

AAPM GEC-ESTRO TG-342: Update On The Robot-assisted Brachytherapy

 

Realtime Ir-192 Source Localization Employing Spatio-temporal Sensing Along Brachytherapy Catheter

 

Simultaneous Catheter And Multi-criteria Optimization For HDR Cervical Cancer Brachytherapy With The Venezia Applicator

 

Introducing A Robotic 3D Ultrasound System For Improved Seroma Visualization And Implant Guidance In Partial Breast Brachytherapy

 

Prediction Of Individualized Brachytherapy Dose For Cervical Cancer Patients Using 3D Cascade UNet

Moderator:

Jennifer M. Croke, MD, MHPE

Princess Margaret Cancer Centre

Panelists:

What’s the Role of Nursing in Brachytherapy Education

Kayla Kafka Peterson, RN
UCLA

How to Mentor Millennials in Procedural Education

Michael R. Folkert, MD, PhD
Northwell Health

GEC-ESTRO Lessons Learned from Teaching IGABT for Cervical Cancer

Remi Nout, MD, PhD
Erasmus MC Rotterdam

Innovations in Teaching Brachytherapy

Lauren Colbert, MD
MD Anderson Cancer Center

Melissa Joyner, MD
MD Anderson Cancer Center

Moderators:

Andrew Farach, MD
Houston Methodist

Arjit Baghwala, MSc, DABR
Houston Methodist

 

Development Of A Novel Dosimetry Software For Patient-specific Intravascular Brachytherapy Treatment Planning On Optical Coherence Tomography Images

 

Development Of Risk Stratification Tool For Predicting Vaginal Bleeding And Improving Safety During Gynecologic Hdr Implant Removals

 

MRI-guided Intraluminal High Dose Rate Brachytherapy In The Management Of Malignant Biliary Tract Obstruction: A Preliminary Analysis

 

I-125 Eye-plaque Seed Economics: To Re-use Or To Not Re-use? Firas Mourtada

 

BrUOG 291: Phase II Trial Of Five-fraction Accelerated Partial Breast Irradiation (APBI) Using Non-invasive Image-guided Breast Brachytherapy (NIBB) (NCT01961531)

 

Efficacy And Pattern Of Failure In High-Dose-Rate Brachytherapy For Penile Cancer: Single-institution Experience

Moderators:

Douglas Hoover, PhD
London Regional Cancer Program

Samantha Lloyd, PhD
British Columbia Cancer Agency

 

3D Printed Phantom To Determine Minimum Curvature Radius Of HDR Afterloader

 

Multicentre Deployment Of A Monte Carlo Model-Based Dose Calculation For LDR Brachytherapy

 

A 3-D Printed Platform For Preclinical In Vitro Studies Incorporating Clinically Relevant HDR And External Beam Therapy Workflows

 

HDR Prostate Brachytherapy In-vivo Source Tracking: To Interrupt Or Adapt?

 

A Magic Gel Formulation Adapted To The Requirements Of Dosimetry For Complex-shaped Low-dose Rate Brachytherapy Devices

 

Prostate Brachytherapy Optimization With 4-pi Catheter Selection And Catheter Complexity Reduction

 

Monte Carlo Based Hetergeneous Dose Calculations For Cesium-131 Implants Treating Recurrent Head And Neck Cancer

 

Quantitative Dosimetric Analysis Of The Impact Of Needle Material On HDR Prostate Plans

 

Color vision for improved ultrasound visualization of brachytherapy needles

 

On The Use Of A Gyn Applicator For The Registration Of An Emt-enabled Afterloader And Ct Scan In Interstitial Gyn Brachytherapy

 

Comparison Of HDR Brachytherapy MCO Planning Using Dosimetrical Versus Radiobiological Criteria For The Treatment Of Prostate Cancer

Moderator:

Mira Keyes, MD, FRCPC, FABS
BC Cancer Agency

Panelists:

Palladium 103: Is There Really an Advantage Over Iodine?

Steven Frank, MD, FABS
MD Anderson Cancer Center

Cesium 131

Ryan P. Smith, MD
University of Pittsburgh

Iodine 125: It's All a Matter of Dose

Richard Stock, MD
Mt. Sinai Medical Center

Moderator:

Susan Richardson, PhD
Swedish Cancer Institute

Panelists:

Physics Perspective on RadioPharm Implementation

Jacqueline E.  Zoberi, PhD
Washington University

MD Perspective on RadioPharm Implementation

Neil Taunk, MD
University of Pennsylvania

Cutting Edge Research

Emily Weg, MD
University of Washington

Moderator:

Chirag Shah, MD
Cleveland Clinic

Panelists:

Modeling Value

Chirag Shah, MD
Cleveland Clinic

Gyn Expert- EBRT vs SBRT

Puja S. Venkat, MD
UCLA

Prostate Expert- EBRT vs SBRT

Peter F. Orio, III, DO, MS
Brigham and Women’s Hospital

Value and New Payment Models

Peter F. Orio, III, DO, MS
Brigham and Women's Hospital

Moderators:

Aman Taggar, MD, MS
Sunnybrook Odette Cancer Centre

Ashley Weiner, MD, PhD
University of North Carolina at Chapel Hill

 

Automating Brachytherapy Treatment Planning For Cervical Cancer Using Neural Network Dose Predictions

 

Prospective Assessment Of Interstitial Needles With Transrectal Ultrasound In Cervical Cancer Brachytherapy

 

3D-Printed Vaginal Individualized Applicator (via) Simplifies Needle Insertion, Guides Needle Distribution, Facilitates Procedure Efficiency And Optimizes Dosimetry For Gynecologic Interstitial Brachytherapy

 

A Randomized Cross-over Study Of A Hydrogel Packing System Compared To Standard Packing During Image-guided High-dose Rate Brachytherapy Boost For Cervical Cancer

 

Direction Modulated Brachytherapy Tandem Model Applicators For Treatment Planning Of Multi-institutional Cervical Cancer Cases: Removing Needles In Intracavitary-interstitial Techniques

 

"Honeycomb" Direction Modulated Brachytherapy Tandem Applicator

Moderator:

Marisa Kollmeier, MD
Memorial Sloan Kettering Cancer Center

Panelists:

Single Institution: Sunnybrook Experience with GU Research

Gerard C. Morton, MD, FRCPC
Sunnybrook Odette Cancer Centre

EMBRACE Perspective on Multi-Institution Research

Remi Nout, MD, PhD
Erasmus MC Rotterdam

Conducting Brachytherapy Trials Through Cooperative Groups

Neal B. Desai, MD
UT Southwestern Medical Center

Ensuring Brachy QA on Clinical Trials

Jyoti S. Mayadev, MD
UC San Diego Health

Lessons Learned from ASCENDE-RT

W. James Morris, MD, FRCPC
BC Cancer Agency

Moderators:

Luc Beaulieu, PhD
CHU De Québec - ULaval

Samantha Simiele, PhD
MD Anderson Cancer Centerr

Panelists:

Auto-planning (Knowledge-Based Planning)

Shirin A. Enger, PhD
McGill University

Artificial Intelligence/Big Data

Xun Jia, PhD
Johns Hopkins University

Innovations in Applicators

Adam M. Cunha, PhD
UCSF Comprehensive Cancer Center

Moderator:

Melissa Joyner, MD
MD Anderson Cancer Center

Panelists:

The Value Proposition of Short-Course Breast Brachytherapy?

Chirag Shah, MD
Cleveland Clinic

Sarcoma

Arash Naghavi, MD, MS
H. Lee Moffitt Cancer Center and Research Institute

Gynecological

Sushil Beriwal, MD, FABS
Allegheny Health Network

Prostate

Daniel J. Krauss, MD
Beaumont Health

Moderator:

Lara Hathout, MD
Rutgers Cancer Institute of New Jersey

Panelists:

Prostate Cases I & II

William McLaughlin, MD
University of Michigan/Providence Cancer Center

GYN Case I

Kathy Han, MD, MSc
Princess Margaret Hospital

GYN Case II

Junzo P. Chino, MD
Duke University Medical Center

Moderators:

John David, MD
University of South Florida

Lin Wang, MSc
Northwell Health System

 

Streamlining Brachytherapy Or Waste Management In 60 Seconds: The AI Solution

 

Novel 3D Printed Universal Conical Holder For Eye Plaque Quality Assurance

 

Trends In Abnormal Occurrences In HDR Brachytherapy In The Past 20 Years

 

Stent Placement Plus Radioactive Seeds Implantation For The Treatment Of Portal Vein Tumor Thrombosis

 

A Novel 3d Printing Method For An Eye Plaque “Dummy” For Ocular Melanoma Brachytherapy

 

Endoluminal High Dose Rate Brachytherapy For Esophageal Cancer

 

Ocular Brachytherapy With I-125 An Increasingly Important Option In Ocular Melanoma: A Case Series From A Low Middle Income Country, Latin American Experience

 

The Impact Of A Positive Covid-19 Test On The Timeliness Of Radiation In Patients Receiving Brachytherapy

 

Explainable Artificial Intelligence To Characterize Receipt Of Brachytherapy Boost In Locally Advanced Cervical Cancer Through The COVID-19 Era

 

Ultra-accelerated Perioperative High Dose Rate Brachytherapy For Early Breast Cancer, Preliminary Results From A Phase II Trial

 

Commissioning Of Three-Dimensional In Vivo Dosimetry For ¹⁷⁷Lu-PSMA Targeted Molecular Radiotherapy Using Quantitative SPECT/CT

 

Surgically Targeted Radiation Therapy (STaRT) For Recurrent Brain Metastases: Initial Clinical Experience

Panelists:

The Situation with Radiotherapy and Brachytherapy in Ukraine

Ruslan Zelinskyi, PhD, President of the Ukrainian Association of Medical Physicists

Brachytherapy During War: A Case Study

Zoia Shepil, MD and Serhii Brovchuk, PhD, Kyiv Regional Oncology Dispensary

A Call for Action and How to Help Ukraine

Nataliya Kovalchuk, PhD, Stanford Radiation Oncology, founder of Help Ukraine Group (HUG)

Moderators:

Arjit Baghwala, MSc, DABR
Houston Methodist

Puja S. Venkat, MD
UCLA

 

A Feasibility Study: Insertion Of Inert Alpha Dart Seeds In Orthotopic Rectal Mice Models

 

Interstitial Brachytherapy For Organ And Function Preservation In Soft Tissue Sarcomas: Long Term Outcomes

 

TO ASSESS THE FEASIBILITY, TOLERABILITY AND OUTCOME OF CONCURRENT CHEMO-RADIATION WITH HDR INTRALUMINAL BRACHYTHERAPY IN ADVANCED IN-OPERABLE CARCINOMA ESOPHAGUS

 

Outcomes With High Dose Rate Brachytherapy In Reirradiation Of Head And Neck Cancers

 

Case Report On Novel 3D-Printed Surface Brachytherapy Applicators For The Scalp In A Rural Setting

 

Surgically Targeted Radiation Therapy (STaRT) For Recurrent Brain Metastases: Initial Clinical Experience

 

Accuracy And Safety Of 3d-printed Non-co-planar Template Assisted ¹²⁵I Seed Implantation For Recurrence In Situ Following Radiotherapy In Patients With Head And Neck Squamous Carcinoma

 

Improving Treatment Quality In Multi-Catheter Breast Brachytherapy By Decision-tree Based Treatment Adaption And Implementation Of Patient Immobilization

Moderators:

Martin King, MD, PhD
Brigham and Women’s Hospital

Pranshu Mohindra, MD, MBBS
Case Western

Judges:

Onyinye Balogun, MD
Weill Cornell Medical

Christopher Deufel, PhD
Mayo Clinic

Elizabeth Kidd, MD
Stanford Cancer Institute Palo Alto

Timothy Showalter, MD
The University Of Virginia

Shark Tank Teams:

Team 1: Incorporating a digital conversational agent to educate cancer patients on brachytherapy and assess its impact on patient satisfaction/understanding
Arpan Prabhu,  Santanu Samanta, Gary Lewis

Team 2: Biological treatment plan optimization of combined brachytherapy and EBRT
Elliot Abbott, Adam Turner, David Brachman

Team 3: Automated intraoperative live-planning and dose visualization
Andre Karius, Vratislav Strnad, Christoph Bert

Moderator:

Daniel J. Krauss, MD
Beaumont Health

Panelists:

Evolution of HDR

Juanita M. Crook, MD, FRCPC, FABS
British Columbia Cancer Agency

Prescription Dose is Just the Beginning

Gerard C. Morton, MD, FRCPC, FABS
Sunny Brook Odette Cancer Centre

Incorporating Advanced Imaging to Boost the DIL

Deidra L. Batchelar, PhD, FCCPM
BC Cancer Agency

Moderator:

Parul N. Barry, MD
University of Pittsburgh

Panelists:

GYN Tumors Involving Bladder/Bowel

Kathy Han, MD, MSc
Princess Margaret Hospital

Vaginal Cancer

Remi Nout, MD, PhD
Erasmus MC Rotterdam

Reirradiation

Alina Sturdza, MD
Medical University of Vienna

Oligometastasis

Junzo P. Chino, MD
Duke University Medical Center

Moderators:

Mark Corkum, MD, MSc
The Ottawa Hospital

Jack Zheng, MD
BC Cancer Agency

 

High-Dose Rate Brachytherapy as Monotherapy in the treatment of Localize Prostate Cancer

 

Doppler Ultrasound Changes Of The Neurovascular Bundle During High Dose Rate Prostate Brachytherapy

 

Biochemical Prostate Cancer Cure After Ultra Hypofrationned Radiotherapy Combined With Hdr Brachytherapy

 

Mature Toxicity And Effectiveness Outcomes Associated With Three Treatment Schedules Of High-dose-rate Brachytherapy Monotherapy For Favorable-risk Prostate Cancer

 

Salvage High-dose-rate Brachytherapy For Prostate Cancer Local Recurrence - Toxicity And Efficacy Comparison Of Two Fractionation Schedules

 

A Prospective Study Of MR-assisted Salvage HDR Prostate Brachytherapy With Intra-prostatic Boost

Moderator:

Alina Sturdza, MD
Medical University of Vienna

Panelists:

Improving Access to GYN Brachytherapy - Tata Experience

Supriya Chopra, MD
Tata Memorial Centre

Improving Access to GYN Brachytherapy - Ghana Perspective

Aba Scott
Korle-Bu Teaching Hospital

Improving Access to GYN Brachytherapy - Botswana/UPenn Partnership

Megan Kassick, MD, MPH
University of Pennsylvania

Promoting High-Quality Physics for LMIC

Julie Raffi, PhD, DABR
Duke University Medical Center

Moderators:

Janna Andrews, MD
Northwell Health

Martin King, MD
Brigham and Women’s Hospital

 

Prostate Brachy 2.0: Accessible & Immersive Virtual Reality Training Curriculum For Prostate Brachytherapy

 

Evaluating The Prognostic Significance Of Artificial Intelligence-Delineated Dominant Intraprostatic Lesion And Prostate Volume Measurements For I-125 LDR Prostate Brachytherapy

 

Utilizing Deep Learning For Auto-segmentation In Prostate Brachytherapy With Implanted Needles

 

Observer Preference Of AI-Generated Versus Clinically-Utilized Prostate Contours For Ultrasound-based High Dose Rate Brachytherapy

 

Salvage Whole Gland With Focal Boost High-Dose-Rate Brachytherapy For Locally Recurrent Prostate Cancer After Prior Radiation Therapy: A Single Institutional Experience Of A Two-Fraction Approach

 

Early Outcomes And Hormone-Free Survival Following Salvage Mars For Mri-Visible Post-Surgical Bed Recurrences And Focal Intraprostatic Recurrences Following External Beam And Following Brachytherapy

 

Encounters For Potential Toxicity Between Prostate Radiation Therapy Modalities: A New York State Cohort Study 2015-2019

 

Ceramides As A Potential Biomarker Of Treatment Outcome And Toxicities Of Prostate Cancer Patients Treated With EBRT And HDR Brachytherapy Boost

 

Evaluation Of Toxicity For A Randomized Trial Of Tri-modality Therapy With Iodine-125 Brachytherapy, External Beam Radiation, And Short- Or Long-term Androgen Deprivation Therapy For High-risk Localized Prostate Cancer (TRIP Trial)

 

Quantitative Analysis Of The Effectiveness Of Combined Radiation And Implantable Magnetic Nanoparticle-induced Hyperthermia In Radiation Therapy

 

Single Fraction High Dose Rate Prostate Brachytherapy In Intermediate-risk Prostate Cancer

Moderator:

Eve Lyn Marchand, MD, PhD
Hôpital Maisonneuve Rosemont

 

How Do You Do It?: Gynecologic Brachytherapy Best Practices At High Volume Institutions Within The United States And Canada

 

Can Bench Inform Bedside? Exploring The Outcomes Gap In Locally Advanced Cervix Cancer, In A Population-based Cohort Treated With Image-guided (Chemo)radiotherapy/brachytherapy

 

The Impact Of MRI-tracking Technology On Procedural Time For Patients Undergoing Perineal Template-based Interstitial Gynecologic Brachytherapy Implants

 

Evaluating Outcomes And Toxicities For A Newly Implemented MRI-Based Brachytherapy Program For Cervical Cancer

 

Gross Tumor Volume Change With MRI Guided Brachytherapy For Locally Advanced Cervical Cancer

 

Low Recurrence Rates Of Equivocal Post Treatment Pet Following HDR Brachytherapy For Locally Advanced Cervical Cancer

 

Combining Novel Direction Modulated Brachytherapy Tandem-and-ovoids Applicators For Treatment Planning Of Multi-institutional Cervical Cancer Cases: Removing Needles In Intracavitary-interstitial Techniques

 

Use Of Superflab During Interstitial Brachytherapy For Highly Locally Advanced Cancer Of The Gynecological Tract To Minimize Toxicity

 

FEBE: The Female Brachytherapy Experience. Assessing PTSD Symptom Rates In Women Treated For Locally Advanced Cervical Cancer With HDR Brachytherapy

 

A Survey Of Patient Experiences With Brachytherapy Education And Preparedness

 

The Impact Of Race On Access To Endometrial Cancer Care And Post-radiation Vaginal Stenosis

 

Lymphovascular Space Invasion (LVSI) In Patients With FIGO III Uterine Cancer Undergoing External-beam Radiotherapy: Implications On Survival And Response To Vaginal Cuff Brachytherapy Boost